Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Erythema × Breast × Clear all
NCT01597921 2012-08-09

A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

Water-Jel

Terminated
50 enrolled
Breast

Breast Neoplasms, Erythema, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡